References
- FerlayJAutierPBoniolMHeanueMColombetMBoylePEstimates of the cancer incidence and mortality in Europe in 2006Ann Oncol200718358159217287242
- RossoSSpitaleABalziDFranceschiSZanettiREstimate of cancer incidence in Italian regions, 2001Epidemiol Prev2004284–524725715732679
- ZanettiRFalciniFSimonatoLVercelliMSurvival of cancer patients in Italy in the nineties: the importance of population based dataEpidemiol Prev2001253 Suppl1811695194
- BarniSVenturiniMBerettaGDAgreement between oncology guidelines and clinical practice in Italy: the ‘right’ program. A project of the Italian Association of Medical Oncology (AIOM)Ann Oncol200718 Suppl 6179184
- SaltzLBCoxJVBlankeCfor the Irinotrecan Study GroupIrinotecan plus fluorouracil and leucovorin for metastatic colorectal cancerN Engl J Med20003431390591411006366
- AndreTBoniCMounedji-BoudiafLOxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancerN Engl J Med2004350232343235115175436
- SchmollHJCartwrightTTaberneroJPhase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patientsJ Clin Oncol200725110210917194911
- FeliuJEscuderoPLlosaFCapecitabine as first-line treatment for patients older than 70 years with metastatic colorectal cancer: an Oncopaz Cooperative Group studyJ Clin Oncol200523133104311115860870
- CassidyJClarkeSDíaz-RubioERandomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancerJ Clin Oncol200826122006201218421053
- GiulianiGLucioniCMazziSDe CarliCJamiesonCEconomic evaluation of oral capecitabine vs intravenous 5-fluorouracil plus leucovorin (Mayo regimen) in the treatment of advanced colorectal cancer [Valutazione di convenienza economica comparata tra un farmaco orale (capecitabina) e una terapia parenterale a base di 5-FU (regime Mayo) nel trattamento del carcinoma del colon-retto metastizzato]PharmacoEconomics – Italian Research Articles2002413138 [Italian.]
- Di CostanzoFRavasioRSobreroACapecitabine versus bolus fluorouracil plus leucovorin (folinic acid) as adjuvant chemotherapy for patients with Dukes’ C colon cancer : economic evaluation in an Italian NHS settingClin Drug Investig20082810645655
- LopatrielloSAmorosoDAlabisoOThe CAP-CR study: direct medical costs in Italian metastatic colorectal cancer patients on first-line infusional 5-fluorouracil or oral capecitabineEur J Cancer200844172615262218805000
- LimatSBracco-NolinCHLegat-FagnoniCEconomic impact of simplified de Gramont regimen in first-line therapy in metastatic colorectal cancerEur J Health Econ20067210711316474968
- WardSKaltenthalerECowanJBrewerNClinical and cost- effectiveness of capecitabine and tegafur with uracil for the treatment of metastatic colorectal cancer: systematic review and economic evaluationHealth Technol Assess200373219314604497